FSSAI and A1/A2 Claims: The August 2024 Advisory, Its Withdrawal, Today’s Position and the Debate

FSSAI and A1/A2 Claims: The August 2024 Advisory, Its Withdrawal, Today’s Position and the Debate

TL;DR

  • On 21 August 2024, FSSAI issued an advisory directing food businesses to remove A1/A2 claims from milk and milk products, including ghee.

  • On 26 August 2024, FSSAI withdrew the advisory for further consultation and stakeholder engagement.

  • The withdrawal did not introduce separate FSSAI-standardised A1 and A2 milk categories or grant blanket approval for every A2-related marketing claim.

  • Indian cattle-genetics studies have documented a high prevalence of the A2 beta-casein variant in several studied indigenous cattle populations, including Sahiwal, Gir and Tharparkar.

  • An animal's A2A2 genotype is a genetic characteristic. It does not, by itself, establish a health benefit for consumers.

  • Ghee requires particular care in labelling because a claim about the milk used to make it is different from a claim about the protein composition of the finished product.

  • Indian dairy brands should communicate A2 sourcing through accurate testing, segregation, traceability and substantiated claims.


What did FSSAI actually say about A1/A2 milk and ghee in 2024, and why was its advisory withdrawn just five days later?

The debate around A1 and A2 dairy in India became particularly prominent in August 2024, when the Food Safety and Standards Authority of India (FSSAI) issued an advisory directing food businesses to remove A1/A2-related claims from milk and dairy products. The advisory specifically referred to ghee, butter and curd, and its wording raised an important question for dairy brands: could a product communicate the type of milk used to make it, or would that description be considered misleading?

Five days later, FSSAI withdrew the advisory for further stakeholder consultation.

That sequence matters. The original advisory was an official regulatory communication, but it was subsequently withdrawn. Its instructions cannot accurately be described as a continuing blanket prohibition. Equally, the withdrawal did not amount to unconditional approval of every A1/A2 claim.

For consumers and dairy businesses, the issue is more substantial than a labelling dispute. It involves three separate questions: whether A1 and A2 beta-casein can be scientifically identified, what the available human research says about their possible effects, and how food businesses should communicate verified product information without making unsupported health promises.

Understanding these distinctions is essential to interpreting the FSSAI episode and to evaluating A2 milk, paneer and ghee in the Indian market.

What are A1 and A2 beta-casein?

Beta-casein is one of the principal proteins found in cow's milk. A1 and A2 refer to two genetic variants of this protein, associated with a variation in the beta-casein gene.

A cow's genotype determines which beta-casein variants it can pass on. Animals are commonly classified into three genotypes:

  • A1A1: The animal carries two A1 variants.

  • A1A2: The animal carries one A1 and one A2 variant.

  • A2A2: The animal carries two A2 variants.

An A2A2 cow can produce milk containing the A2 beta-casein variant. However, the genotype of an individual animal should not be confused with the composition of an entire dairy supply. A claim about a milk supply depends on the animals contributing to it, milk segregation, and reliable sourcing records.

This distinction is particularly relevant in India, where indigenous cattle breeds have an important place in dairy production.

What does Indian cattle-genetics research tell us?

Indian researchers have investigated A1/A2 beta-casein variants across indigenous and crossbred cattle populations. Several studies have reported a high prevalence of the A2 variant among sampled indigenous cattle.

A 2022 study published in Frontiers in Genetics examined the distribution of A1/A2 beta-casein variants across native Indian cattle breeds. It reported a high frequency of the A2-type haplotype in the studied indigenous populations. The findings add to the scientific understanding of beta-casein variation in Indian cattle.

Research involving breeds such as Sahiwal, Gir, Tharparkar, Rathi and Red Sindhi has also contributed to this understanding. The study's findings can be examined in its published analysis of A1/A2 beta-casein variants across native Indian cattle breeds.

A useful example comes from a 2019 study by Kumar and colleagues, which examined 660 cattle: 354 Vrindavani crossbred animals and 306 Sahiwal cattle. Among the sampled Sahiwal population, researchers reported 87% A2A2 and 13% A1A2 genotypes, with no A1A1 animals identified in that sample. The reported A2 allele frequency was 0.94. These findings are available in the study of A1/A2 beta-casein alleles in Vrindavani and Sahiwal cattle.

These figures apply to the animals examined, not every Sahiwal herd or Indian dairy supply. Nevertheless, they demonstrate that A2 beta-casein is a documented genetic characteristic found at a high frequency in several studied indigenous cattle populations.

An ICAR-Central Institute for Research on Cattle article, A1 and A2 milk – What science claims?, also discusses the genetic distinction and the limitations of evidence concerning proposed human health effects.

The important distinction is that cattle-genetics research establishes the presence and distribution of protein variants. It does not, by itself, prove that consuming one variant produces a particular health outcome in people.

The FSSAI advisory: What happened in August 2024?

The regulatory discussion became prominent when FSSAI issued an advisory on 21 August 2024, titled Clarification regarding Selling/Marketing of Milk & Milk products such as Ghee, Milk etc in the name of A1 & A2.

The advisory referred to the Food Safety and Standards (Food Products Standards and Food Additives) Regulations, 2011. FSSAI stated that the existing standards did not recognise a differentiation between A1 and A2 milk.

It considered A1/A2 claims on milk and milk products, including milk-fat products, misleading in the context of those standards. Food businesses were directed to remove such claims from product labels and marketing material. The advisory also addressed claims on e-commerce platforms and provided six months for businesses to exhaust pre-printed packaging material.

The original FSSAI advisory issued on 21 August 2024 set off uncertainty across India's dairy sector. Brands selling A2 milk and related products had to consider how the direction could affect packaging, product descriptions, online listings and sourcing communication.

However, the advisory did not remain in force for long.

The withdrawal and India's regulatory position

On 26 August 2024, FSSAI issued a further order stating that the 21 August advisory stood withdrawn for further consultation and engagement with the stakeholders.

The wording matters. FSSAI withdrew the advisory; it did not announce a new A1/A2 classification system. Nor did the withdrawal amend existing milk standards or establish unrestricted permission to make every A1/A2-related claim.

Date or position

What happened

What it means for dairy businesses

21 August 2024

FSSAI issued its advisory on A1/A2 claims in milk and milk products, including ghee.

Businesses were directed to remove the specified claims under the advisory.

26 August 2024

FSSAI withdrew the advisory for further consultation and stakeholder engagement.

The 21 August direction was withdrawn; this was not blanket approval of all A1/A2 claims.

Existing 2011 standards

The standards did not establish separate A1 and A2 milk categories.

Businesses should not describe A1 and A2 as separate FSSAI-standardised milk categories.

General labelling and advertising requirements

Applicable requirements concerning accuracy, substantiation and misleading representations continue to apply.

A2-related statements should be clear, supportable and consistent with the actual product and its records.

Position identified in the FSSAI material reviewed for this article

No A1/A2-specific replacement prohibition or blanket approval was identified.

Brands should not interpret withdrawal as unrestricted permission or as a new regulatory classification.

The practical position is that the withdrawal removed the specific August 2024 advisory, but the broader regulatory framework remains relevant. Food businesses must continue to comply with applicable FSSAI standards, labelling rules and advertising and claims requirements.

The relevant framework can be checked through FSSAI's food safety and standards regulations, its advertising and claims regulations and its labelling and display amendments.

Why did the advisory create a debate?

The disagreement brought together different concerns within India's dairy industry.

The consumer-information argument

Supporters of A2-related product information argue that consumers should be able to understand the source and characteristics of the milk they purchase. If a dairy sources milk from genetically verified A2A2 animals and maintains proper segregation, that can represent a meaningful sourcing distinction.

This is particularly relevant to indigenous cattle programmes. Documented sourcing can help consumers understand where their milk comes from and how a dairy manages its supply.

The standards and scientific-substantiation argument

Critics have questioned whether A1/A2 labels are sometimes used to suggest a proven health advantage. R.S. Sodhi, former managing director of Amul and former president of the Indian Dairy Association, challenged claims that one protein type is necessarily better than another. His position was reported in ThePrint's coverage of the A1/A2 labelling debate.

This argument should be understood as a challenge to unsupported superiority claims, not as evidence that A1 and A2 genetic variants do not exist.

The distinction is central: the existence of different beta-casein variants is a matter of cattle genetics. Claims about their effects on human health require a different level of evidence.

The indigenous cattle and consumer-choice argument

The debate also has implications for Indian indigenous cattle. A2 prevalence in several native breeds has made the subject relevant to breed conservation, dairy sourcing and the market for milk from indigenous cattle.

Consumer choice depends on reliable information. However, that information must be verifiable. A label should reflect the actual sourcing and production system rather than rely only on a breed name or a broad marketing statement.

Can ghee be called A2?

Ghee requires a separate discussion because its composition is different from that of liquid milk.

Under Indian food standards, ghee is a milk-fat product with a minimum milk-fat content of 99.5%. During clarification, water and most milk solids-not-fat are removed. Beta-casein is a milk protein, not a milk-fat component.

This creates an important distinction between two possible statements.

“Made from milk sourced from A2A2 cows”

This is a statement about the origin of the milk used to prepare the ghee. It requires credible animal-genotype records, milk segregation, sourcing documentation and traceability through processing.

“Contains A2 beta-casein”

This is a statement about the composition of the finished ghee. It is different from a source claim and requires evidence relating to the finished product itself.

A dairy brand should not treat these statements as interchangeable. Describing the source of the milk is not the same as demonstrating that a particular protein remains in the finished product.

For a brand using traditional Bilona preparation, explaining the milk source and production process can be more informative than making an unsupported claim about the protein composition of the finished ghee.

How can A2 claims be verified?

A credible A2 sourcing claim requires more than identifying a cow as belonging to an indigenous breed. Breed identity and beta-casein genotype are related research subjects, but they are not substitutes for testing an individual animal.

Molecular methods, including PCR-based approaches, are used in research to identify A1 and A2 beta-casein variants. Such testing can establish whether an animal carries the A1 or A2 variant.

For a dairy business, verification should extend beyond the initial test:

  • Animal identification: Maintain records linking each tested animal to its identity.

  • Genotype reports: Keep reports showing the tested animal's beta-casein genotype.

  • Milk segregation: Ensure milk from the relevant animals is collected and handled separately where the claim requires it.

  • Supply-chain traceability: Maintain records connecting farm-level milk to processing batches and finished products.

  • Batch documentation: Retain production and quality records so that sourcing claims can be checked.

  • Accurate communication: Describe what has actually been tested and verified without extending the claim into unsupported health promises.

These steps help distinguish a documented sourcing programme from a label based only on general breed associations.

What does Indian evidence establish about health claims?

The evidence discussed above supports the existence of A1 and A2 beta-casein variants and documents their distribution in studied Indian cattle populations.

That is not the same as establishing a health advantage for Indian consumers. Cattle-genetics studies cannot independently demonstrate that consuming A2 milk prevents, treats or improves a medical condition.

The Indian research considered for this article does not establish robust Indian human clinical evidence for broad health-benefit claims. Therefore, brands should avoid presenting genetic findings as clinical proof.

A responsible approach is to communicate verifiable characteristics: the cattle genotype, milk source, sourcing process, production method, and traceability system. This allows consumers to understand what makes a product distinct without turning a sourcing claim into a medical promise.

What should Indian dairy brands communicate today?

The August 2024 episode highlights why precise product communication matters.

Brands should avoid presenting A1 and A2 as separate FSSAI-standardised milk categories. They should also avoid implying that withdrawal of the advisory automatically authorises every A2-related claim.

Instead, businesses should build their communication around evidence they can produce. If a product is sourced from A2A2-genotyped cows, the business should be able to explain how the animals were tested, how milk is segregated and how batches are traced.

For ghee, the distinction between milk provenance and finished-product composition deserves particular care. A source-based statement should not be rewritten as a claim that the finished product contains a specific milk protein unless that composition is independently established.

For consumers, the most useful questions are straightforward: Where does the milk come from? What evidence supports the genotype claim? Is the milk segregated? Can the brand explain its traceability process?

How Moovana approaches A2 dairy

Moovana's A2 dairy positioning centres on the sourcing and production of its dairy products, including Bilona ghee, A2 milk and A2 paneer.

The broader discussion around A1/A2 labelling reinforces the importance of explaining product identity accurately. Consumers should be able to understand the milk source and production process without relying on exaggerated health claims.

For Bilona ghee, the distinction between the source milk and the composition of the finished product is especially important. Clear sourcing communication and responsible product descriptions help consumers make informed decisions.

Explore Moovana's Bilona ghee, available for delivery across India. Moovana's milk and paneer are available for delivery in Siliguri.

Frequently Asked Questions

Is A2 milk labelling banned in India?

The FSSAI advisory issued on 21 August 2024, which directed businesses to remove A1/A2 claims, was withdrawn on 26 August 2024 for further consultation. The withdrawal was not blanket approval of all A2 claims. Businesses must continue to follow applicable food standards, labelling and advertising requirements.

What is the current FSSAI position on A1 and A2 milk?

The 2011 food-product standards do not establish separate A1 and A2 milk categories. The August 2024 advisory was withdrawn, and the FSSAI material reviewed for this article did not identify a subsequent A1/A2-specific replacement prohibition or blanket approval. General requirements for truthful and substantiated claims continue to apply.

Are Indian indigenous cattle more likely to carry the A2 variant?

Several Indian studies have reported high A2 allele frequencies among sampled indigenous cattle populations, including breeds such as Sahiwal, Gir and Tharparkar. However, breed-level findings should not replace individual animal testing.

Can ghee be called A2?

A brand may wish to communicate that its ghee is made from milk sourced from A2A2-genotyped cows. That is a source claim. It is different from claiming that the finished ghee contains A2 beta-casein. The evidence and wording must match the claim being made.

Does A2 milk have proven health benefits?

Indian cattle-genetics research establishes the presence and distribution of A2 beta-casein variants. It does not, by itself, establish human health benefits. Broad medical or therapeutic claims require appropriate human clinical evidence and must comply with applicable advertising and claims regulations.

Back to blog